AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K

Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung

(2010) Donatella Malanga et al.   CELL CYCLE

Molecular Mechanism of an Oncogenic Mutation That Alters Membrane Targeting: Glu17Lys Modifies the PIP Lipid Specificity of the AKT1 PH Domain†

(2008) Kyle E. Landgraf et al.   BIOCHEMISTRY

Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias

(2008) M S Kim et al.   BRITISH JOURNAL OF CANCER

Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms

(2008) Louis S. Pymar et al.   HUMAN MOLECULAR GENETICS

PKBα/Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival

(2008) Lana Bozulic et al.   MOLECULAR CELL

AKT1 E17K in human solid tumours

(2008) F E Bleeker et al.   ONCOGENE